Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Pompe Care Podcast Series 2

What has been your experience with switching patients from alglucosidase alfa to avalglucosidase alfa?

Current Treatment Landscape & hands on Experience

What makes avalglucosidase alfa different from alglucosidase alfa in terms of clinical efficacy and patient outcomes?

Advances in Therapy: Avalglucosidase Alfa & Future Innovations

How can you see changing the lives of patient starting taking Nexviazyme and if you can share from your experience couple of patient stories that realy impacted positively from staring the treatment for Pompe disease?

From your experience

Thank You!

The End

Structured Monitoring for Early Detection of Fabry Progression

Renal Outcomes After Switching to Agalsidase Beta: A Single-Center Analysis

Dupilumab for Patients with AFRS

The Many Faces of Limb-Girdle Weakness

Differentail Diagnosis for Unspecific Limb - Girdle Muscular Dystrophy (LGMD)/ Dr. Alanood Alsolaihim

When the Heart, Kidneys, and Nerves Intersect

Differentail Diagnosis for Patient with Unexplained Neuropathic Pain, Unknown LVH, or Dialysis Requirements. Dr. Khalid Naji

When Weakness Tells a Bigger Story

It's Not Just A Wakness/ Dr. Ahmed Bamaga

The Enlarged Spleen Mystery

Patient With Hepatosplenomegaly and Multiple Splenic lesions/Dr. Ahmed Al Shomer